Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 monoclonal antibody
The Journal of Allergy and Clinical Immunology | Jun 16, 2018
Prevalence of patients eligible for anti-IL-5 treatment in a cohort of adult-onset asthma
The Journal of Allergy and Clinical Immunology: In Practice | Jun 14, 2018
Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: Comparison between methotrexate and cyclosporine
Journal of the European Academy of Dermatology and Venereology | May 31, 2018
Analysis of HLA-B allelic variation and interferon-gamma ELISpot responses in patients with severe cutaneous adverse reactions associated with drugs
The Journal of Allergy and Clinical Immunology: In Practice | May 28, 2018
Efficacy and safety of switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (E/C/F/TAF) in virologically suppressed women
Journal of Acquired Immune Deficiency Syndromes | May 27, 2018